Latest Market Launch News

Page 5 of 7
LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.
Victor Sage
Victor Sage
29 July 2025
Adslot Ltd has activated its StoreFront digital advertising platform across multiple international markets, driving $148.9 million in total transaction value for FY25 amid significant cost savings and a growing sales pipeline.
Sophie Babbage
Sophie Babbage
25 July 2025
PEXA’s UK arm has secured a formal commitment from NatWest to implement its digital platform for remortgage and sale & purchase transactions, marking a pivotal step in PEXA’s UK expansion.
Sophie Babbage
Sophie Babbage
24 July 2025
PPK Group’s majority-owned PowerPlus Energy launches two Clean Energy Council-approved batteries eligible for the Australian Government’s new Cheaper Home Batteries Program rebates, positioning itself to capture a significant share of the emerging residential energy storage market.
Maxwell Dee
Maxwell Dee
22 July 2025
Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.
Ada Torres
Ada Torres
9 July 2025
Cochlear Limited has secured FDA approval for its latest Nucleus Nexa System and Kanso 3 sound processors, setting the stage for a US market debut in early FY26.
Ada Torres
Ada Torres
8 July 2025
Terragen Holdings has been granted a US patent for its microbial feed supplements, reinforcing its position in the animal probiotics market and supporting plans for US market entry.
Ada Torres
Ada Torres
3 July 2025
EMVision Medical Devices has activated five of six pivotal trial sites for its emu™ bedside brain scanner, advancing towards FDA clearance while launching a parallel innovation study in Australia.
Ada Torres
Ada Torres
2 July 2025
Audinate Group Limited has acquired Iris, a US-based SaaS platform for remote AV device control, in a deal valued up to US$28 million. This move strengthens Audinate’s video and control capabilities within its Dante ecosystem.
Sophie Babbage
Sophie Babbage
25 June 2025
Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.
Ada Torres
Ada Torres
17 June 2025
EMVision Medical Devices has secured a $5 million non-dilutive government grant to accelerate global commercialisation of its innovative First Responder portable brain scanner, aimed at revolutionising pre-hospital stroke and brain injury care.
Ada Torres
Ada Torres
16 June 2025
PainChek has advanced its US regulatory approval process with a positive FDA meeting, setting the stage for a potential market debut of its pain assessment app in late 2025.
Ada Torres
Ada Torres
5 June 2025